Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Calvez

Showing results (301-310 of 329) with videos related to

Pageof 33
Sort By:
Antiviral Therapy|January 21, 2015
Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant womenMinh P Lê, Laurent Mandelbrot, Diane Descamps, et al.
Antiviral Therapy|October 1, 2004
Clinically validated genotype analysis: guiding principles and statistical concernsFrançoise Brun-Vézinet, Dominique Costagliola, Mounir Ait Khaled, et al.
Microbiology Spectrum|March 20, 2025
Development of a new high-yield integration site assay reveals disease-specific patterns across HTLV-1-associated pathologiesVincent Guiraud, Jérôme Alexandre Denis, Sofia Ben Attia, et al.
Plos One|August 26, 2014
A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAARTDaniele Armenia, Cathia Soulie, Domenico Di Carlo, et al.
Aging Cell|June 12, 2026
Opposing Association of Lung Neutrophils and PD-L1<sup>+</sup> Monocytes in Age-Related Severity of SARS-CoV-2 InfectionSerban Morosan, Clémence Granier, Noëlline Guillou, et al.
The Journal of Antimicrobial Chemotherapy|June 17, 2008
HIV-1-infected patients from the French National Observatory experiencing virological failure while receiving enfuvirtideDiane Descamps, Lambert Assoumou, Bernard Masquelier, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2015
Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 UsageClaudia Alteri, Matteo Surdo, Maria Concetta Bellocchi, et al.
The Journal of Antimicrobial Chemotherapy|January 6, 2015
Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patientsSlim Fourati, Charlotte Charpentier, Corinne Amiel, et al.
The Journal of Antimicrobial Chemotherapy|October 23, 2010
Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in FranceDiane Descamps, Marie-Laure Chaix, Brigitte Montes, et al.
Viruses|February 28, 2023
Prevalence of HIV-1 Natural Polymorphisms and Integrase-Resistance-Associated Mutations in African ChildrenDjeneba B Fofana, Houdou Diarra, Ibrahima Guindo, et al.
Pageof 33

Showing results (301-310 of 329) with videos related to

Sort By:
Pageof 33
Antiviral Therapy|January 21, 2015
Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant womenMinh P Lê, Laurent Mandelbrot, Diane Descamps, et al.
Antiviral Therapy|October 1, 2004
Clinically validated genotype analysis: guiding principles and statistical concernsFrançoise Brun-Vézinet, Dominique Costagliola, Mounir Ait Khaled, et al.
Microbiology Spectrum|March 20, 2025
Development of a new high-yield integration site assay reveals disease-specific patterns across HTLV-1-associated pathologiesVincent Guiraud, Jérôme Alexandre Denis, Sofia Ben Attia, et al.
Plos One|August 26, 2014
A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAARTDaniele Armenia, Cathia Soulie, Domenico Di Carlo, et al.
Aging Cell|June 12, 2026
Opposing Association of Lung Neutrophils and PD-L1<sup>+</sup> Monocytes in Age-Related Severity of SARS-CoV-2 InfectionSerban Morosan, Clémence Granier, Noëlline Guillou, et al.
The Journal of Antimicrobial Chemotherapy|June 17, 2008
HIV-1-infected patients from the French National Observatory experiencing virological failure while receiving enfuvirtideDiane Descamps, Lambert Assoumou, Bernard Masquelier, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2015
Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 UsageClaudia Alteri, Matteo Surdo, Maria Concetta Bellocchi, et al.
The Journal of Antimicrobial Chemotherapy|January 6, 2015
Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patientsSlim Fourati, Charlotte Charpentier, Corinne Amiel, et al.
The Journal of Antimicrobial Chemotherapy|October 23, 2010
Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in FranceDiane Descamps, Marie-Laure Chaix, Brigitte Montes, et al.
Viruses|February 28, 2023
Prevalence of HIV-1 Natural Polymorphisms and Integrase-Resistance-Associated Mutations in African ChildrenDjeneba B Fofana, Houdou Diarra, Ibrahima Guindo, et al.
Pageof 33